Hot topics close
 

Pfizer CEO says coronavirus vaccine could be ready by late November

Pfizer CEO Albert Bourla announced the company's Covid-19 vaccine could be available by late November. Yahoo Finance's Anjalee Khemlani weighs in.
Similar news
  • Current COVID-19 Impact on Glioblastoma Treatment Drugs Market Research 2020 With Strategic Analysis of Key ...
  • Pfizer (PFE) Progressing Well With its Coronavirus Program
  • Future Insights in Global Systemic Oral Azoles Market (2020 – 2029) || Novartis AG, Pfizer, Sanofi-Aventis
  • Global Topical Corticosteroids Market Outlook 2019 – 2025 : AstraZeneca plc, GlaxoSmithKline plc, Merck & Co., Inc ...
  • Global Neuromyelitis Optica Drug Market to Witness Exponential Growth by 2026 with top key players like Pfizer ...
  • GlaxoSmithKline closes deal with Pfizer for consumer healthcare ...
  • GlaxoSmithKline closes deal with Pfizer for consumer healthcare joint venture
  • GlaxoSmithKline closes deal with Pfizer for consumer healthcare joint venture
  • Antipsychotic Drugs Market Analysis Reports Revenue Growth during the Forecast Period 2019-2027 including Major ...
  • Pfizer 'deliberately buried' data showing its arthritis drug might also prevent Alzheimer's 'because it wouldn't have made ...
  • Pfizer focuses on regional China after price cuts hit sales
  • Profitable Strategic Report on Organ Transplant Immunosuppressant Drugs Market by 2024 | Profiling Global Players ...
  • Phenomenal study on Anxiety Disorders And Depression Treatment Market Progresses for Huge Profits by 2025 with ...
  • Muscle Relaxants Drugs Market Expects to See Significant Growth During 2019-2026: Key Players- Pfizer, Allergan ...
This week's most popular news